Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / N•• B•• H•••••••• I•••

N•• B•• H•••••••• I•••

Stage unknownSouth San Francisco, CABiotechnology
Facts
Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Jul 5, 2024
    Form D equity offering · $73.2M (form d sold) · 25 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “N•• B•• H•••••••• I••• filed Form D: $73,223,979 sold of $122,039,949, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
7 officers, 7 directors
Timeline
2
  1. Mar 27, 2026
    N•• B•• H•••••••• I••• filed Form D/A: $142,039,949 sold of $142,039,949, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jul 17, 2024
    N•• B•• H•••••••• I••• filed Form D: $73,223,979 sold of $122,039,949, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company